Pharmaceutical outsourcing is predicted to grow to $60 billion by 2022. The rise in outsourcing strategies in addition to rapid technological change invariably means there are more IT providers; new systems, changes to existing systems and decommissioning. We are all familiar with the advantages of outsourcing such as; to reduce and control costs, provide a competitive advantage and freeing up of internal resources. However, the rise in outsourcing has led to an increase demand in audits.
Audits and assessments are an integral part of the quality strategy within the Pharmaceutical industry. For example,